The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea 1 2Abbreviations: AZT, zidovudine; CQ, chloroquine; ddI, didanosine; HU, hydroxyurea; LPS, lipopolysaccharide; NRTI, nucleoside reverse transcriptase inhibitor; PMA, phorbol myristate acetate; and RT, reverse transcriptase.-Reference-Cited by-同舟云学术

The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea 1 2Abbreviations: AZT, zidovudine; CQ, chloroquine; ddI, didanosine; HU, hydroxyurea; LPS, lipopolysaccharide; NRTI, nucleoside reverse transcriptase inhibitor; PMA, phorbol myristate acetate; and RT, reverse transcriptase.

Published:2001-06 Issue:12 Volume:61 Page:1531-1535
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Boelaert Johan R,Sperber Kirk,Piette Jacques

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference18 articles.

1. Low levels of deoxynucleotides in peripheral blood lymphocytes;Gao;Proc Natl Acad Sci USA,1993

2. Hydroxyurea and HIV;Lori;AIDS,1999

3. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2′,3′-dideoxynucleoside activities against replication of human immunodeficiency virus;Gao;Proc Natl Acad Sci USA,1995

4. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes;Sperber;AIDS Res Hum Retroviruses,1993

5. Inhibition of HIV-1 replication by hydroxychloroquine;Chiang;Clin Ther,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (2R, 4S, 5S) 1-(4-(4-(((7-Chloroquinolin-4-yl)amino)methyl)-1H-1,2,3-triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;Molbank;2023-07-03

2. COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19;Current Medicinal Chemistry;2022-06

3. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review;Travel Medicine and Infectious Disease;2020-05

4. Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review;Therapeutic Advances in Musculoskeletal Disease;2020-01

5. Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications;Viruses;2017-07-06